As employers face growing challenges in addressing obesity and its related conditions, the Midwest Health Purchasers Collaborative (MHPC), a non-profit employer purchasing organization and arm of the Midwest Business Group on Health, has partnered with Vida Health, a virtual obesity and metabolic center of excellence, to provide employers with cost-effective […]
Trending News
Spring Health Study Published in JAMA Network Open Demonstrates 1.9x ROI of Employer-Sponsored Behavioral Health Benefits
Spring Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored mental health benefits. The study, published in JAMA Network Open, sets a new benchmark in the behavioral health space, and reveals […]
Alegeus and Empower Forge Partnership to Bring Together Health and Wealth
Alegeus, the market leader in healthcare benefit and payment solutions, today announced it has entered into a major strategic partnership with Empower, a leading provider of retirement and wealth management services. The new partnership coincides with the launch of Empower’s Consumer Directed Health Solutions business and positions the company to […]
Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug (IND) / Clinical Trial Application (CTA) for the study of ALY-101 in patients suffering from Alopecia Areata (AA). The Phase 2a trial will […]
MYndspan and BIOS Health Partner to Make Consumer-Scale Precision Neuroscience a Reality
MYndspan, a pioneer in consumer brain health technology, and BIOS Health, a leader in real-time neural data analysis and dosing, today announced a partnership to scale the reach and impact of precision neuroscience. By combining MYndspan’s Magnetoencephalography (MEG) powered brain scans with BIOS Health’s proprietary neural data and AI platform, […]
Rentschler Biopharma announces strategic realignment of its global business operations
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of a long-term strategic shift. As part of this realignment, Rentschler Biopharma will withdraw from the field of cell and gene therapy, ceasing operations at […]
MemorialCare Long Beach Medical Center Becomes First in California to Adopt Stryker’s New Q Guidance System with Spine Guidance Software
MemorialCare Long Beach Medical Center is the first in the California to adopt Stryker’s Q Guidance System with Spine Guidance Software. This system revolutionizes spinal surgery by enabling precise, computer-assisted navigation for both open and minimally invasive spine procedures. By integrating optical tracking capabilities, sophisticated algorithms, and advanced instrumentation, the […]
Ryght AI and Cancer Research SA (CRSA) Partner to Enhance Cancer Clinical Trials in South Australia
Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to advance cancer clinical trials in South Australia. Through this collaboration, CRSA will join the Ryght Research Network, leveraging […]
Raintree Systems Acquires Rehab Therapy AI Technology Leader Yoomi Health
Raintree announced today that it has acquired Yoomi Health, a New York-based leader in AI technologies for rehab therapy organizations. This critical addition to Raintree’s product stack will significantly accelerate the Artificial Intelligence and Machine Learning roadmap for Raintree clients. In addition to a series of strategic investments made over […]
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204, an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or absence of […]
